Bala Subramanian, PhD, highlights how the novel antibiotic BWC0977, with its dual intravenous and oral formulation, is poised to transform the fight against antimicrobial resistance.
Bala Subramanian, PhD
Advertisement
COO and head of R&D at Bugworks
Articles by Bala Subramanian, PhD
Advertisement
Latest Updated Articles
Bugworks' Antibiotic BWC0977 Targets Resistant PathogensPublished: September 6th 2024 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
Practically Expanding AI's role in Infectious Diseases
2
ID Week Brings Education, Networking and Conference Events Altogether Into One Conference
3
Maternal and Infant RSV Immunization Safe, Boosts Antibody Levels Regardless of Sequence
4
HIV Providers: Shortages and Uneven Distribution Across the US
5
